பிரபாஷ் ரஞ்சன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரபாஷ் ரஞ்சன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரபாஷ் ரஞ்சன் Today - Breaking & Trending Today

Walk the talk on TRIPS waiver - The Hindu


Walk the talk on TRIPS waiver
Updated:
Updated:
The government should offer Covaxin’s technology to domestic pharmaceutical companies and foreign corporations
Share Article
The government should offer Covaxin’s technology to domestic pharmaceutical companies and foreign corporations
Member countries of the World Trade Organization (WTO) are under an obligation to ensure that their domestic intellectual property rights (IPR) laws conform to the requirements of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement. When the pandemic hit the globe, India and South Africa piloted the proposal to waive key provisions of the TRIPS agreement on COVID-19 vaccines, drugs, therapeutics, and related technologies. The core idea is that IPRs such as patents should not become barriers in scaling up production of medical products essential to combat COVID-19. The TRIPS waiver proposal, now backed by the U.S., is essential because it would give im ....

South Africa , United States , Eli Lilly , Supreme Court , Incyte Holdings Corporation , World Trade Organization , Trade Related Aspects , Intellectual Property Rights , Patents Act , Holdings Corporation , Walk The Talk On Trips Waiver , Prabhash Ranjan , Co Vid , Compulsory Licences , ஒன்றுபட்டது மாநிலங்களில் , எலி லில்லி , உச்ச நீதிமன்றம் , உலகம் வர்த்தகம் ஆர்கநைஸேஶந் , வர்த்தகம் தொடர்புடையது அம்சங்கள் , அறிவுசார் ப்ராபர்டீ உரிமைகள் , காப்புரிமைகள் நாடகம் , ஹோல்டிங்ஸ் நிறுவனம் , பிரபாஷ் ரஞ்சன் , இணை வித் ,

A TRIPS waiver is useful but not a magic pill


A TRIPS waiver is useful but not a magic pill
Updated:
Updated:
May 10, 2021 07:44 IST
The U.S.-supported move will have an effect if countries simultaneously address non-IP bottlenecks among other things
Share Article
AAA
The U.S.-supported move will have an effect if countries simultaneously address non-IP bottlenecks among other things
The United States has finally relented and declared its support for a temporary waiver of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement for COVID-19 vaccines at the World Trade Organisation (WTO). In October 2020, India and South Africa, at the WTO, proposed waiving Sections 1, 4, 5, and 7 of Part II of the TRIPS agreement (covering copyrights, industrial designs, patents, and undisclosed trade information) related to the prevention, containment, or treatment of COVID-19. ....

South Africa , United States , Prabhash Ranjan , Katherine Tai , European Union , Asian University , World Trade Organisation , Trade Related Aspects , Intellectual Property Rights , South Asian University , ஒன்றுபட்டது மாநிலங்களில் , பிரபாஷ் ரஞ்சன் , க்யாதரிந் தை , ஐரோப்பிய தொழிற்சங்கம் , ஆசிய பல்கலைக்கழகம் , உலகம் வர்த்தகம் ஆர்கநைஸேஶந் , வர்த்தகம் தொடர்புடையது அம்சங்கள் , அறிவுசார் ப்ராபர்டீ உரிமைகள் , தெற்கு ஆசிய பல்கலைக்கழகம் ,

WTO to again discuss Covid vaccine IPR waiver proposal by India, South Africa on Thursday


WTO to again discuss Covid vaccine IPR waiver proposal by India, South Africa on Thursday
Under the proposal, India and South Africa have sought temporary relaxations for IP, patents and other such provisions laid out under the TRIPS Agreement of the WTO.
Nayanima Basu 19 April, 2021 5:54 pm IST
Text Size:
A+
New Delhi: India and South Africa’s proposal to temporarily waive the intellectual property and patent rights on Covid vaccines will be discussed at yet another round of informal meeting of the World Trade Organization (WTO)’s TRIPS Council Thursday, even as the US continues to oppose the move.
The meeting will take place at the WTO headquarters in Geneva, according to the global trade body. ....

Jammu And Kashmir , South Africa , New Delhi , South African , Ebrahim Patel , Piyush Goyal , Leena Menghaney , Joe Biden , Prabhash Ranjan , Katherine Tai , Adar Poonawalla , Ngozi Okonjo Iweala , Medecins Sans Frontiere Access Campaign , World Trade Organization , Asian University , Astrazeneca Plc , Serum Institute Of India , Novavax Inc , Trade Related Aspects , Intellectual Property Rights , Industry Minister Piyush Goyal , South African Trade Minister Ebrahim Patel , Legal Studies , South Asian University , Serum Institute , ஜம்மு மற்றும் காஷ்மீர் ,

Scaling up vaccine production - The Hindu


Scaling up vaccine production
Updated:
Updated:
April 12, 2021 23:07 IST
There are several legal means that the government should employ to scale up production of COVID-19 vaccines
Share Article
AAA
A health worker showing COVID-19 vaccine at a dispensary in New Delhi.
  | Photo Credit: Shiv Kumar Pushpakar
There are several legal means that the government should employ to scale up production of COVID-19 vaccines
The precarious second wave of COVID-19 infections has hit India with greater ferocity than the first. Despite a year to prepare, we have been caught woefully off guard again. Multiple reports of the scarcity of COVID-19 vaccines and drugs have surfaced from different parts of the country. According to the Observer Research Foundation, till the end of March, India had produced 316 million doses of Covishield and Covaxin the two COVID-19 vaccines in use in India. Of this, 64.5 million doses have been exported. This suggests that t ....

New Delhi , Prabhash Ranjan , Observer Research Foundation , National Institute Of Virology , Asian University , Indian Council Of Medical Research , Serum Institute Of India , Haffkine Biopharmaceutical Corporation , Epidemic Diseases Act , Cosmetics Act , Bharat Biotech , Patents Act , Indian Council , Medical Research , National Institute , Principal Lawyer , South Asian University , Scaling Up Vaccine Production , Murali Neelakantan , Co Vid , Drugs And The Cosmetics Act , புதியது டெல்ஹி , பிரபாஷ் ரஞ்சன் , பார்வையாளர் ஆராய்ச்சி அடித்தளம் , தேசிய நிறுவனம் ஆஃப் வைராலஜி , ஆசிய பல்கலைக்கழகம் ,